Literature DB >> 6839073

The treatment of writer's cramp with multimodal behaviour therapy and biofeedback: a study of 15 cases.

J A Cottraux, C Juenet, L Collet.   

Abstract

Of 15 patients with writer's cramp (4 females, 11 males, mean age 36, range 23-50, mean duration 3.6 years), 13 entered a behavioural treatment. Nine received a multimodal treatment, and four EMG feedback alone. Four patients dropped out during the treatment phase. Nine patients were considered as improved at a follow-up between 1 and 9 months. A stress-coping model is put forward to account for the therapeutic effectiveness, and to explain the drop-outs. Writer's cramp seems to be related to stressful situations at work. The existence of personality and biological factors remains to be demonstrated.

Entities:  

Mesh:

Year:  1983        PMID: 6839073     DOI: 10.1192/bjp.142.2.180

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Combined cognitive-behavioural and mindfulness programme for people living with dystonia: a proof-of-concept study.

Authors:  H Sandhu; C J Bernstein; G Davies; N K Y Tang; M Belhag; A Tingle; M Field; J Foss; A Lindahl; M Underwood; D R Ellard
Journal:  BMJ Open       Date:  2016-08-05       Impact factor: 2.692

2.  Aberrant Oscillatory Activity during Simple Movement in Task-Specific Focal Hand Dystonia.

Authors:  Leighton B N Hinkley; Rebecca Dolberg; Susanne Honma; Anne Findlay; Nancy N Byl; Srikantan S Nagarajan
Journal:  Front Neurol       Date:  2012-11-28       Impact factor: 4.003

Review 3.  Basic and supplementary sensory feedback in handwriting.

Authors:  Jérémy Danna; Jean-Luc Velay
Journal:  Front Psychol       Date:  2015-02-20

Review 4.  Behavioural interventions for people living with adult-onset primary dystonia: a systematic review.

Authors:  C J Bernstein; D R Ellard; G Davies; E Hertenstein; N K Y Tang; M Underwood; H Sandhu
Journal:  BMC Neurol       Date:  2016-03-22       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.